PCL Based Biopolymers with Extended Range and PossibilitiesThe NeedPCL has been a key material in modern medicine and advanced medical device manufacturing. Able to degrade away slowly in the body without producing toxic residues, PCL has been used for medical implants and controlled drug release over time. However, PCL is inherently hydrophobic and has set degradation kinetics that cannot be adjusted, limiting its relevance in other biomedical applications such as tissue engineering or drug delivery when PCL’s degradation rate is too fast or slow.
The TechnologyOSU faculty have developed a way to expand and adjust PCL’s material properties; crystallinity, thermal behavior, hydrophilicity, and degradation rates. By modifying the PCL monomer chemical structure before polymerization occurs the physical characteristics of PCL can be tuned to the end application need. Additionally, by shifting performance control upstream to the polymer chemistry itself, manufacturers are enabled to achieve application specific material without increasing formulation complexity or manufacturing processes. Polymerization of these modified PCL monomers is still in line with established industrial polymerization processes.
Benefits/AdvantagesOur approach allows one to tune how dense and ordered (firmer, crystalline) or disordered (soft, permeable) the final polymer is, unlocking the ability to modify numerous physical and chemical properties like:
|
Tech IDT2026-219 CollegeCollege of Arts and Sciences (ASC) Licensing ManagerPanic, Ana Inventors(None) Categories |